Abstract
Purpose
To study the long-term intraocular pressure (IOP) and visual outcomes in treated aniridic glaucoma.
Methods
A retrospective chart review of patients with aniridia and glaucoma, with ≥ 2-year follow-up, was performed. Eyes in early glaucomatous stages were medically managed, while moderate-severe stage eyes underwent a trabeculectomy with mitomycin-c (MMC). Success was termed ‘complete’ when average final IOP was ≤ 18 mmHg without usage of glaucoma medications, and ‘qualified’ when with/without topical glaucoma therapy. A significant change in vision was defined as > 2-line change on Snellen vision chart or > 0.2 change in logMAR units in in either direction (better or worse).
Results
Thirty-five eyes of 20 patients were included. The mean duration of follow-up was 7.29 ± 5.75 years. Associated ocular anomalies were present in 19 eyes (54.29%). Twelve eyes (34.28%) were maintained on medical management, while 23 eyes (65.71%) had undergone a trabeculectomy with MMC. The mean baseline IOP was 31.46 ± 6.34 mmHg, and mean IOP on last follow-up was 13.25 ± 5.82 mmHg, p < 0.001. Seventy-five percent of the medically managed eyes achieved an IOP ≤ 18 mmHg. 52.17% and 95.65% of the surgically treated eyes achieved ‘complete’ and ‘qualified’ success respectively. The median best corrected visual acuity (BCVA) at baseline was 1.48(0.6–2) logMAR units and on final follow-up was 1.3 (0.48–5) logMAR units, p = 0.21. Fifty percent of the eyes remained stable, 35.71% showed an improvement and 14.29% a deterioration of > 0.2 logMAR units. Patients with a longer follow-up (> 10 years) and those who had undergone a trabeculectomy with MMC were more likely to show good IOP control (p = 0.003; p = 0.004 respectively).
Conclusion
Aniridic glaucoma can be managed efficiently by medications in early glaucomatous neuropathy, and with trabeculectomy augmented with mitomycin-C and releasable sutures for more advanced glaucomas, offering favourable long-term IOP control, visual stability and safety.
![](http://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00417-021-05335-5/MediaObjects/417_2021_5335_Figa_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00417-021-05335-5/MediaObjects/417_2021_5335_Fig1_HTML.png)
Similar content being viewed by others
References
Lee H, Khan R, O’Keefe M (2008) Aniridia: current pathology and management. Acta Ophthalmol (Copenh) 86:708–715. https://doi.org/10.1111/j.1755-3768.2008.01427.x
Chang JW, Kim JH, Kim S-J, Yu YS (2014) Congenital aniridia: long-term clinical course, visual outcome, and prognostic factors. Korean J Ophthalmol KJO 28:479–485. https://doi.org/10.3341/kjo.2014.28.6.479
Brauner SC, Walton DS, Chen TC (2008) Aniridia. Int Ophthalmol Clin 48:79–85. https://doi.org/10.1097/IIO.0b013e318169314b
Gramer E, Reiter C, Gramer G (2012) Glaucoma and frequency of ocular and general diseases in 30 patients with aniridia: a clinical study. Eur J Ophthalmol 22:104–110. https://doi.org/10.5301/EJO.2011.8318
Calvão-Pires P, Santos-Silva R, Falcão-Reis F, Rocha-Sousa A (2014) Congenital aniridia: clinic, genetics, therapeutics, and prognosis. Int Sch Res Not 2014:. https://doi.org/10.1155/2014/305350
Landsend ECS, Lagali N, Utheim TP (2021) Congenital aniridia-a comprehensive review of clinical features and therapeutic approaches. Surv Ophthalmol. https://doi.org/10.1016/j.survophthal.2021.02.011
Grant WM, Walton DS (1974) Progressive changes in the angle in congenital aniridia, with development of glaucoma. Trans Am Ophthalmol Soc 72:207–228
Panda A, Sood NN, Agarwal HC (1982) Management of secondary glaucoma in aniridia. Indian J Ophthalmol 30:311–313
Jain A, Gupta S, James MK et al (2015) Aniridic glaucoma: long-term visual outcomes and phenotypic associations. J Glaucoma 24:539–542. https://doi.org/10.1097/IJG.0000000000000019
Moschos MM, Nitoda E, Fenzel I et al (2019) Prognostic factors of pediatric glaucoma: a retrospective study. Int Ophthalmol 39:359–373. https://doi.org/10.1007/s10792-018-0819-0
Selvan H, Pujari A, Kishan A et al (2021) Trabeculectomy on animal eye model for resident surgical skill training: the need of the hour. Curr Eye Res 46:78–82. https://doi.org/10.1080/02713683.2020.1776880
Balekudaru S, Sankaranarayanan N, Agarkar S (2017) Prevalence, incidence, and risk factors for the development of glaucoma in patients with aniridia. J Pediatr Ophthalmol Strabismus 54:250–255. https://doi.org/10.3928/01913913-20170322-01
Nascimento E, Silva R, Shen LQ, Chiou CA et al (2019) Glaucoma management in patients with aniridia and Boston type 1 keratoprosthesis. Am J Ophthalmol 207:258–267. https://doi.org/10.1016/j.ajo.2019.06.018
Chen TC (1960) Walton DS (1999) Goniosurgery for prevention of aniridic glaucoma. Arch Ophthalmol Chic Ill 117:1144–1148. https://doi.org/10.1001/archopht.117.9.1144
Samant M, Chauhan BK, Lathrop KL, Nischal KK (2016) Congenital aniridia: etiology, manifestations and management. Expert Rev Ophthalmol 11:135–144. https://doi.org/10.1586/17469899.2016.1152182
AlDarrab A, Malik R (2018) Bilateral deep sclerectomy with microperforations as a successful secondary procedure in aniridia-associated glaucoma. Middle East Afr J Ophthalmol 25:52–55. https://doi.org/10.4103/meajo.MEAJO_291_17
Viestenz A, Seitz B, Deland E et al (2018) Clinical anatomy of the anterior chamber angle in congenital aniridia and consequences for trabeculotomy/cyclophotocoagulation. Clin Anat N Y N 31:64–67. https://doi.org/10.1002/ca.22935
Fieß A, Shah P, Sii F et al (2017) Trabeculectomy or transscleral cyclophotocoagulation as initial treatment of secondary childhood glaucoma in Northern Tanzania. J Glaucoma 26:657–660. https://doi.org/10.1097/IJG.0000000000000682
Almousa R, Lake DB (2014) Intraocular pressure control with Ahmed glaucoma drainage device in patients with cicatricial ocular surface disease-associated or aniridia-related glaucoma. Int Ophthalmol 34:753–760. https://doi.org/10.1007/s10792-013-9868-6
Barthakur R, Shrestha SP, Bhat KS, Natarajan M (2009) Management of glaucoma in a case of familial aniridia by trabeculectomy. Nepal J Ophthalmol Biannu Peer-Rev Acad J Nepal Ophthalmic Soc NEPJOPH 1:75–76
Wiggins RE (1960) Tomey KF (1992) The results of glaucoma surgery in aniridia. Arch Ophthalmol Chic Ill 110:503–505
Adachi M, Dickens CJ, Hetherington J et al (1997) Clinical experience of trabeculotomy for the surgical treatment of aniridic glaucoma. Ophthalmology 104:2121–2125. https://doi.org/10.1016/s0161-6420(97)30041-4
Suhr AW, Lim MC, Brandt JD et al (2012) Outcomes of fornix-based versus limbus-based conjunctival incisions for glaucoma drainage device implant. J Glaucoma 21:523–529. https://doi.org/10.1097/IJG.0b013e318227a565
Durai I, Pallamparthy S, Puthuran GV et al (2021) Outcomes of glaucoma drainage device implantation and trabeculectomy with mitomycin c in glaucoma secondary to aniridia: AADI versus trabeculectomy in aniridia. Am J Ophthalmol. https://doi.org/10.1016/j.ajo.2021.03.008
Okada K, Mishima HK, Masumoto M et al (2000) Results of filtering surgery in young patients with aniridia. Hiroshima J Med Sci 49:135–138
Mandal AK, Walton DS, John T, Jayagandan A (1997) Mitomycin C-augmented trabeculectomy in refractory congenital glaucoma. Ophthalmology 104:996–1001; discussion 1002-1003. https://doi.org/10.1016/s0161-6420(97)30195-x
Lee H, Meyers K, Lanigan B, O’Keefe M (2010) Complications and visual prognosis in children with aniridia. J Pediatr Ophthalmol Strabismus 47:205–210; quiz 211–212. https://doi.org/10.3928/01913913-20090818-07
Nelson LB, Spaeth GL, Nowinski TS et al (1984) Aniridia. A review. Surv Ophthalmol 28:621–642. https://doi.org/10.1016/0039-6257(84)90184-x
Walton DS (1986) Aniridic glaucoma: the results of gonio-surgery to prevent and treat this problem. Trans Am Ophthalmol Soc 84:59–70
Al-Obeidan SA, Osman EE-DA, Dewedar AS et al (2014) Efficacy and safety of deep sclerectomy in childhood glaucoma in Saudi Arabia. Acta Ophthalmol (Copenh) 92:65–70. https://doi.org/10.1111/j.1755-3768.2012.02558.x
Arroyave CP, Scott IU, Gedde SJ et al (2003) Use of glaucoma drainage devices in the management of glaucoma associated with aniridia. Am J Ophthalmol 135:155–159
Author information
Authors and Affiliations
Contributions
Conceptualization: Ramanjit Sihota, Tanuj Dada.
Methodology: Ramanjit Sihota, Harathy Selvan, Kishan Azmira.
Formal analysis and investigation: Ramanjit Sihota, Harathy Selvan, Ajay Sharma, Amish Gupta, Ashish Upadhyay.
Writing–original draft preparation: Harathy Selvan.
Writing–review, editing and final approval: All authors.
Supervision: Ramanjit Sihota, Tanuj Dada.
Corresponding author
Ethics declarations
Research involving human participants
An informed consent was taken from adult participants and legal guardian of all pediatric patients to participate and publish the results of the study. All procedures performed in this study involving human participants was in accordance with the ethical standards of the institutional Ethics committee, All India Institute of Medical Sciences, New Delhi, India, and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Conflicts of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sihota, R., Selvan, H., Azmira, K. et al. Improving long-term intraocular pressure and visual outcomes in eyes with aniridic glaucoma. Graefes Arch Clin Exp Ophthalmol 259, 3749–3755 (2021). https://doi.org/10.1007/s00417-021-05335-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-021-05335-5